Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Receivables (2016 - 2025)

Eastman Chemical (EMN) has disclosed Receivables for 17 consecutive years, with $999.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables rose 13.14% year-over-year to $999.0 million, compared with a TTM value of $999.0 million through Dec 2025, up 13.14%, and an annual FY2025 reading of $999.0 million, down 14.76% over the prior year.
  • Receivables was $999.0 million for Q4 2025 at Eastman Chemical, down from $1.3 billion in the prior quarter.
  • Across five years, Receivables topped out at $1.7 billion in Q2 2021 and bottomed at $883.0 million in Q4 2024.
  • Average Receivables over 5 years is $1.3 billion, with a median of $1.3 billion recorded in 2022.
  • The sharpest move saw Receivables skyrocketed 31.22% in 2021, then dropped 27.92% in 2023.
  • Year by year, Receivables stood at $1.2 billion in 2021, then rose by 8.87% to $1.3 billion in 2022, then decreased by 9.63% to $1.2 billion in 2023, then dropped by 23.48% to $883.0 million in 2024, then grew by 13.14% to $999.0 million in 2025.
  • Business Quant data shows Receivables for EMN at $999.0 million in Q4 2025, $1.3 billion in Q3 2025, and $1.3 billion in Q2 2025.